Outcome: After 8 months, retinopathy severity unchanged (stable mild NPDR) versus historic 6-12 month worsening pattern
Shares were down moderately in 2025 through mid-April
By activating additional receptors, dual and triple agonists can tap into a broader set of levers at once, offering the chance for greater weight reduction, improved glycemic control, and (possibly) fewer side effects compared to GLP-1 monotherapy
The reaction mechanism of 1-Cys Prdx (Prdx6) is different from that of the 2-Cys Prdxs, because the 1-Cys Prdx lacks a COOH-terminal Cys residue 34
Molecules 26 , 6530 (2021)
Research suggests that diets higher in unsaturated fats are associated with better metabolic health and may be more supportive of natural GLP-1 responses than diets high in saturated fat